SPONSOR
Cambridge University Hospitals NHS Foundation Trust
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Pancreatic CancerGDMHypoglycemiaCoronary Artery DiseaseMyocardial Infarction (MI)CABG
Cambridge University Hospitals NHS Foundation Trust is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Pancreatic Cancer, GDM, Hypoglycemia, Coronary Artery Disease.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Cambridge University Hospitals NHS Foundation Trust
How many clinical trials has Cambridge University Hospitals NHS Foundation Trust sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Cambridge University Hospitals NHS Foundation Trust, of which 3 are actively recruiting participants. These trials cover conditions including Pancreatic Cancer, GDM, Hypoglycemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Cambridge University Hospitals NHS Foundation Trust research focus on?
Cambridge University Hospitals NHS Foundation Trust clinical trials span Pancreatic Cancer, GDM, Hypoglycemia, Coronary Artery Disease, Myocardial Infarction (MI), and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Cambridge University Hospitals NHS Foundation Trust clinical trial?
To participate in a Cambridge University Hospitals NHS Foundation Trust trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Cambridge University Hospitals NHS Foundation Trust trials with current recruitment status updated daily.
Clinical Trials by Cambridge University Hospitals NHS Foundation Trust
NCT05093231 Phase 2
Recruiting
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Pancreatic Cancer
NCT04192422
Recruiting
DiGESTnewborn Study
GDM
NCT07610538
Recruiting
Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells
Coronary Artery Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology